Latest News

    UHN Launches Behind the Breakthrough Podcast

    500 500 UHN Solutions

    UHN is excited to launch a new podcast series called “Behind the Breakthrough“. Featuring interviews with scientists from across UHN, the podcast reveals the motivation behind their pursuit of answers to important questions—what is the cure for Alzheimer disease? How can we help prevent the elderly from falling? Will stem cells regenerate damaged hearts? How…

    read more

    Point-of-Care Fluorescence Imaging for Chronic Wounds and its Significant Clinical Benefits are Featured at the Largest Canadian Wound Care Conference in 5 Clinical Talks and Posters

    720 746 UHN Solutions

    NIAGARA FALLS, Canada and TORONTO, Canada – (October 4, 2019) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time visualization of bacteria for chronic wounds, and its i:X point-of-care fluorescence imaging device are featured prominently at the Wounds Canada 2019 Annual Conference. The conference, which is the largest Canadian wound care clinical conference, is being held…

    read more

    UHN Research’s Gordon Keller Receives Ogawa-Yamanaka Stem Cell Prize

    1024 730 UHN Solutions

    World-renowned stem cell scientist Gordon Keller, PhD, is the recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize awarded by the Gladstone Institutes for his work with pluripotent stem cells. Dr. Keller is the Director of the McEwen Stem Cell Institute at the University Health Network, Senior Scientist at Princess Margaret Cancer Centre and Professor in…

    read more

    photonamic Acquires Oncology Business from UHN Spin-off MolecuLight

    550 550 UHN Solutions

    photonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight Inc. (Canada) August 14th, 2019  photonamic GmbH & Co. KG (Head office: Pinneberg, Germany; CEO: Ulrich Kosciessa, Ph.D.) (“photonamic”), a subsidiary of SBI Holdings, Inc. (Head office: Minato-ku,Tokyo; Representative Director, President and CEO: Yoshitaka Kitao) is engaged in the business of pharmaceutical development…

    read more